Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Business Channel.
Press releases published on May 6, 2025
Unitil Reports First Quarter Earnings
GlobeNewswire
·
May 6, 2025
HAMPTON, N.H., May 06, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) today announced Net Income of $27.5 million, or $1.69 in Earnings Per Share (EPS), for the quarter ended March 31, 2025, an increase of $0.3 million in Net Income, …
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 6, 2025
FREDERICK, Md., May 06, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the first quarter ended …
The Best Creatine for Muscle Growth is Ultimate CRN-5: Here's Why
GlobeNewswire
·
May 6, 2025
New York, May 06, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why Ultimate CRN-5 by Crazy Nutrition stands out as the best creatine for muscle growth in 2025 The science behind creatine and how it supports muscle growth, strength, and …
FundedX Introduces 24-Hour Payout Guarantee, Fueling Record Growth in Prop Trading Sector
GlobeNewswire
·
May 6, 2025
Photo Courtesy of FundedX DUBAI, United Arab Emirates, May 06, 2025 (GLOBE NEWSWIRE) -- FundedX, a global proprietary trading firm, now guarantees 24-hour payouts for qualified traders. This operational update highlights the company's focus on efficiency …
H&R Block Announces Quarterly Cash Dividend
GlobeNewswire
·
May 6, 2025
KANSAS CITY, Mo., May 06, 2025 (GLOBE NEWSWIRE) -- H…
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development
GlobeNewswire
·
May 6, 2025
Positive Phase 1 data from lead program, SENTI-202, recently presented at the AACR Annual Meeting: SENTI-202 was generally well tolerated, preliminary RP2D identified; 4 of 7 patients achieved composite Complete Remission (cCR) (3 CR, 1CRh), all 4 cCR …
Kodiak Copper to Present Live at the Metals & Mining Virtual Investor Conference May 7th
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Kodiak Copper Corp. (the “Company” or “Kodiak”) (TSX-V: KDK, OTCQB: KDKCF, Frankfurt: 5DD1), today announces that Claudia Tornquist, CEO, will present live at the Metals …
nCino to Host 2025 Investor Day
GlobeNewswire
·
May 6, 2025
WILMINGTON, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will host its Investor Day in Charlotte, North Carolina on May 20, 2025, from 1:00 to 3:00 pm EST. Investor …
WinVest Acquisition Corp. Announces Postponement of Special Meeting of Stockholders to May 30, 2025
GlobeNewswire
·
May 6, 2025
Cambridge, MA, May 06, 2025 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (OTC: WINV, the “Company”) announced today that its upcoming special meeting of stockholders (the “Special Meeting”), which was initially scheduled for 11:00 a.m., Eastern Time, on …
California Resources Reports First Quarter 2025 Financial and Operating Results
GlobeNewswire
·
May 6, 2025
Returned $258 Million to Stakeholders, Maintained Balance Sheet Strength, Delivered Flat Quarter-Over-Quarter Total Net Production Company Reaffirms its 2025 Production, Capital Investment and Adjusted EBITDAX Guidance LONG BEACH, Calif., May 06, 2025 ( …
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 6, 2025
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop …
His Highness Shaikh Mohammed Bin Sultan Bin Hamdan Al Nahyan acquires Warrants of Diginex Limited to Purchase 6.75 Million Ordinary Shares of Diginex for USD$300 million via a Private Transaction
GlobeNewswire
·
May 6, 2025
LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”)(NASDAQ: DGNX), a global leader in ESG sustainable RegTech, is pleased to announce that His Highness Shaikh Mohammed Bin Sultan Bin Hamdan Al Nahyan, a member of the Abu Dhabi Royal Family …
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
GlobeNewswire
·
May 6, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 …
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025
GlobeNewswire
·
May 6, 2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 …
Asure Software Sets May & June 2025 Investor Conference Schedule
GlobeNewswire
·
May 6, 2025
AUSTIN, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, is scheduled to participate at the following financial conferences during May and …
Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 6, 2025
THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 3rd Annual H.C. Wainwright BioConnect Investor Conference, taking place …
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 6, 2025
Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with initial clinical data expected 2H25 New strategic collaboration with Lilly ExploR…
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
GlobeNewswire
·
May 6, 2025
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of …
MacroGenics Announces Date of First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …
Host Hotels & Resorts, Inc. Announces Pricing Of $500 Million Of 5.700% Senior Notes Due 2032, By Host Hotels & Resorts, L.P.
GlobeNewswire
·
May 6, 2025
BETHESDA, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Host Hotels …